Evidence map›Paper›PMID 37047777›Full record

ArticleInternational journal of molecular sciences2023

Monitoring Nrf2/ARE Pathway Activity with a New Zebrafish Reporter System.

Lorenzo Badenetti, Rosa Manzoli, Michela Rubin, Giorgio Cozza, Enrico Moro

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Integrating Time-ResolvedEnvironmental science & technology · 2024
    Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lorenzo BadenettiDepartment of Women's and Children's Health, University of Padova, I-35128 Padova, Italy.
Rosa ManzoliDepartment of Molecular Medicine, University of Padova, I-35121 Padova, Italy.
Michela RubinDepartment of Molecular Medicine, University of Padova, I-35121 Padova, Italy.
Giorgio CozzaDepartment of Molecular Medicine, University of Padova, I-35121 Padova, Italy.ORCID 0000-0002-5155-4682
Enrico MoroDepartment of Molecular Medicine, University of Padova, I-35121 Padova, Italy.ORCID 0000-0003-3166-8102
University of Padua · IT

Funding

National MPS Society 1261University of Padua Moro - PRID 2021
6 · The paper itself

Abstract

Among multiple cytoprotective mechanisms, eukaryotic cells exhibit a complex transcriptional program relying on the Nrf2 transcription factor, which is generally recruited upon biological stressors including oxidative-stress-based cellular insults. The relevance of this master regulator has remarkably emerged in recent years in several research fields such as cancer, inflammatory disorders and age-related neurological diseases. Here, we document the generation and characterization of a novel Nrf2/ARE pathway biosensor fish which exhibits a dynamic spatiotemporal expression profile during the early developmental stages. The transgenic line is responsive to known Nrf2 pathway modulators but also to Edaravone, which direct activity on the Nrf2 pathway has never been documented in a live transgenic fish model. We also show that the reporter is faithfully activated during fin regeneration, and its degree of expression is slightly affected in a glucocerebrosidase (Gba1) morphant zebrafish model. Therefore, this novel transgenic fish may represent a valuable tool to be exploited for the characterization of zebrafish models of human diseases, as well as for primary high-throughput drug screening.

Indexed as

NF-E2-Related Factor 2ZebrafishAnimalsAnimals, Genetically ModifiedAntioxidantsHumansOxidative StressZebrafish ProteinsAntioxidantsNF-E2-Related Factor 2Zebrafish ProteinsdrugNrf2transgenic reporterzebrafish

Identifiers

PMID37047777
PMCPMC10095123
OpenAlexW4362670978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.